Search
CareDx Inc
CDNAAdd to Watchlist
53.860USD
+0.030+0.06%
Market hours 09/21, 09:36（ET）
2.77BMarket Cap
LossP/E TTM
More Details of CareDx Inc Company
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
CareDx Inc Profile
Ticker SymbolCDNA
Company nameCareDx Inc
IPO dateJul 17, 2014
CEOHanna (John W)
Number of employees644
Security typeOrdinary Share
Fiscal year-endJul 17
Address8000 Marina Blvd
CityBRISBANE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94005
Phone14152872300
Websitehttps://www.caredx.com/
Ticker SymbolCDNA
IPO dateJul 17, 2014
CEOHanna (John W)
Company Executives of CareDx Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
114.18K
-39.15%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
114.18K
-39.15%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
114.18K
-39.15%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
37.25K
+26.30%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
37.25K
+26.30%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
37.25K
+26.30%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
152.96K
+6.40%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
114.18K
-39.15%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
114.18K
-39.15%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
114.18K
-39.15%
FAQs
Who are the top five shareholders of CareDx Inc?
The top five shareholders of CareDx Inc are: Dr. Frederick E. (Fred) Cohen, M.D.
How many institutions hold shares of CareDx Inc (CDNA)?
As of 2026Q1, 469 institutions hold shares of CareDx Inc, with a combined market value of approximately 52.46M, accounting for 101.54% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -9782235.00.
What is the biggest source of revenue for CareDx Inc?
In 2026Q1, the Testing Service revenue business generated the highest revenue for CareDx Inc, amounting to 99.93M and accounting for 75.73% of total revenue.